Serological biomarkers of tissue turnover can early identify responders to infliximab in Crohn's disease

van Haaften, W. T., Mortensen, J. H., Olesen, M. L., Karsdal, M. A., Olinga, P., Bay-Jensen, A. -C. & Dijkstra, G., 1-Feb-2017, In : Journal of Crohn's and Colitis. 11, p. S57-S57 1 p.

Research output: Contribution to journalMeeting AbstractAcademic

ID: 42705200